Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_018078.4(LARP1B):c.671A>G(p.Glu224Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
LARP1B (HGNC:24704): (La ribonucleoprotein 1B) This gene encodes a protein containing domains found in the La related protein of Drosophila melanogaster. La motif-containing proteins are thought to be RNA-binding proteins, where the La motif and adjacent amino acids fold into an RNA recognition motif. The La motif is also found in proteins unrelated to the La protein. Alternative splicing has been observed at this locus and multiple variants, encoding distinct isoforms, are described. Additional splice variation has been identified but the full-length nature of these transcripts has not been determined. [provided by RefSeq, Jun 2013]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Feb 21, 2024
The c.671A>G (p.E224G) alteration is located in exon 8 (coding exon 6) of the LARP1B gene. This alteration results from a A to G substitution at nucleotide position 671, causing the glutamic acid (E) at amino acid position 224 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of glycosylation at Y226 (P = 0.0591);Gain of glycosylation at Y226 (P = 0.0591);.;Gain of glycosylation at Y226 (P = 0.0591);Gain of glycosylation at Y226 (P = 0.0591);.;.;.;